Advertisement

Picture EBD Group ChinaBio Partnering Forum 2020 Digital Event CBPF2020 650x80
Document › Details

Prilenia Therapeutics B.V.. (6/3/20). "Press Release: Presentation by Dr. Michael Hayden at the Jefferies Virtual Conference".

Organisations Organisation Prilenia Therapeutics B.V.
  Group Prilenia (Group)
  Organisation 2 Forbion Capital Partners (NL)
Products Product pridopidine
  Product 2 Jefferies 2020 Virtual Healthcare Conference
Index terms Index term Teva–Prilenia: pridopidine, 201809 establishment of Prilenia with acquisition of pridopidine from Teva
  Index term 2 Prilenia–Leucadia: investor conference, 202006 supply service Prilenia presents at Jefferies 2020 Virtual Healthcare Conference
Persons Person Hayden, Michael R. (Prilenia Therapeutics 202006– CEO former President Global RnD + CSO at Teva)
  Person 2 Mulder, Geert-Jan (Forbion Capital Partner 201509 General Partner before ABN AMRO Capital)
     


   
Record changed: 2020-06-06

Advertisement

Picture [iito] Männer Ballett 650x80px

More documents for Prilenia (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group ChinaBio Partnering Forum 2020 Digital Event CBPF2020 650x80




» top